Treatments of symptoms and relapses of multiple sclerosis;Traitements de la poussee et des symptomes de la sclerose en plaques

Revue du Praticien

Volumn 49, Issue 17, 1999, Pages 1877-1881

  Brassat, David ^a   Clanet, Michel ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; CORTICOTROPIN; DANTROLENE; METHYLPREDNISOLONE; SEROTONIN AGONIST; SILDENAFIL;

FATIGUE; HUMAN; MICTURITION DISORDER; MULTIPLE SCLEROSIS; PAIN; QUALITY OF LIFE; RELAPSE; REVIEW; SEXUAL DYSFUNCTION; SPASTICITY; ARTICLE; DISEASE COURSE; PATHOLOGY; RECURRENT DISEASE;

DISEASE PROGRESSION; FATIGUE; HUMANS; MULTIPLE SCLEROSIS; PAIN; QUALITY OF LIFE; RECURRENCE; URINATION DISORDERS;

EID: 0033230995     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Durelli L, Cocito D, Riccio A et al. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: Clinical-immunologic correlations. Neurology 1986 ; 36 : 238-43.
2. Miligan NM, Newcombe R, Compston DAS. A double-blind controlled trial of high dose methylprednisolone in patients with multiple slerosis: I. clinical effects. J Neurol Neurosurg Psych 1987 ; 50 : 511-6.
3. Oliveri RL, Valentino P, Russo C et al. Randomized trial comparing two different high doses of methylprednisolone in MS. Neurology 1998 ; 50 : 1833-6.
4. Alam SM, Kyriakides T, Lawden M, Newman PK. Methylprednisolone in multiple sclerosis : a comparison of oral with ntravenous therapy at equivalent high dose. J Neurol Neurosurg Psych 1993 ; 56 : 1219-20.
5. Barnes D, Hughes RAC, Morris RW et al. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet 1997 ; 349 : 902-6.
6. Beck R, Cleary PA, Anderson MM, Keltner JL, Shults WT, Kaufman DJ. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992 ; 326 : 581-8.
7. Sellebjerg F, Schaldemose J, Frederiksen JL, Olesen J. A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis. Neurology 1999 ; 52 : 1479-84.
8. Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Neurology 1997 ; 49 : 1404-13.
9. Kapoor R, Miller DH, Jones SJ et al. Effects of intravenousq methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology 1998 ; 50 : 230-7.
10. Anderson PB, Goodkin DE. Glucocorticosteroid therapy for multiple sclerosis: a critical review. J Neurol Sci 1998 ; 160 : 16-25.